This indicates that i) Tie2−/membrane E-cadherinlow cells transdifferentiate in vivo into epithelial Tie2+/E-cadherinhigh cells (through MET) and ii) primitive Tie2−/cytoplasmic E-cadherin cells (i.e. potential cancer stem cells) are maintained during tumor growth. This evidence concerns the gene TEK and cancer.